Overall, on-site inspections by the NMPA play a critical role in ensuring that registered medical devices meet stringent regulatory standards in China. Manufacturers must proactively prepare for and manage these inspections to minimize disruptions and maintain compliance, thereby safeguarding their market presence and operational continuity.